VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (1908)	8/5/1997 11:46:00 AM
From: Andrew H	of 9719

TO ALL: CYTO shareholders, there is a letter being sent to CYTO management by a number of those on the CYTO thread--if you would like to sign, see CYTO thread for details. Good questions, Stan. Below is a quote from McKearn's letter: >>In the case of Quadramet, on May 21 the process of regulatory clearance at DuPont Merck and CYTOGEN was complete. Also on that date, clinics and physicians who wished to use Quadramet could begin the process of obtaining or amending their radioisotope licenses. From a practical point of view, this means that product sales for Quadramet could not be initiated at such facilities until the four to eight week process of user license/amendment was completed. Revenue from the sale of Quadramet will therefore not be expected to flow in any meaningful way until the third quarter of this year. << From this, it sounds like they did what they could. Who knows? Regarding Shannon, sounds like she had some sharp and smart docs who were looking ahead. Don't know the particulars.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next